| 750538 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.08 The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study |
2021-10-01 |
10.1136/jitc-2021-itoc8.20 |
Salmi S, Lin A, Hirschovits-Gerz B, Valkonen M, Aaltonen N, Sironen R, Siiskonen H, Pasonen-Seppänen S |
| 750537 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.01 Safety and Efficacy Study of Pembrolizumab in Combination With LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant as Neoadjuvant TherapY——PLENTY Randomized Clinical Trial |
2021-10-01 |
10.1136/jitc-2021-itoc8.5 |
Feng H, Xia Q, PLENTY committee |
| 750536 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P07.03 ‘myTcell’: a smartphone applicationguides logisticsand management of CAR T-cell & BiTE related toxicities |
2021-10-01 |
10.1136/jitc-2021-itoc8.44 |
Blumenberg V, Siegmund L, Fröhlich L, Bergwelt M, Bücklein V, Subklewe M |
| 750535 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.06 Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence |
2021-10-01 |
10.1136/jitc-2021-itoc8.18 |
Dum D, Henke TLC, Mandelkow T, Bady E, Simon R, Sauter G, Steuerer S, Wilczak W, Burandt E, Raedler J, Lennartz M, Blessin NC |
| 750534 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P09.07 Novel insights into immune-independent functions of immune checkpoint inhibitors in oesophageal adenocarcinoma; potential implications for designing combination immuno-chemotherapy regimens to achieve synergistic responses |
2021-10-01 |
10.1136/jitc-2021-itoc8.57 |
Davern M, Buckley C, Fitzgerald C, Heeran AB, Donlon NE, McGrath J, O’ Brien R, O’ Connell F, Murphy B, Lynam-Lennon N, Reynolds JV, Maher SG, Sheppard AD, Bhardwaj A, Bhardwaj A, Butler C, Ravi N, Lysaght J |
| 750533 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.09 Heteromerization of uPA and PAI-1 enforces pro-tumorigenic neutrophil trafficking to malignant tumors in breast cancer via VLDLr-dependent β2 integrin clustering |
2021-10-01 |
10.1136/jitc-2021-itoc8.21 |
Uhl B, Mittmann L, Dominik J, Hennel R, Smiljanov B, Haring F, Schaubächer J, Braun C, Padovan L, Pick R, Canis M, Schulz C, Mack M, Gutjahr E, Sinn P, Heil J, Steiger K, Kanse SM, Weichert W, Sperandio M, Lauber K, Krombach F, Reichel C |
| 750532 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P08.05 Combined pharmacological targeting of adenosine 2a- and 2b-receptor enhances CAR T cell function |
2021-10-01 |
10.1136/jitc-2021-itoc8.49 |
Seifert M, Benmebarek M, Cadilha B, Jobst J, Dörr J, Lorenzini T, Dhoqina D, Zhang J, Zhang J, Schindler U, Endres S, Kobold S |
| 750531 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P08.01 Rationale of using the combination of anti-PD-1 antibody and anti-IL-8 antibody for the pancreatic cancer treatment |
2021-10-01 |
10.1136/jitc-2021-itoc8.45 |
Li P, Rozich N, Wang J, Gai J, Wang J, Xu Y, Herbst B, Yu R, Muth S, Niu N, Li K, Fune V, Osipov A, Wolfgang C, Lei M, Liang T, Zheng L |
| 750530 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P03.02 Protein-based cancer vaccine combined with an oncolytic vaccine promotes potent antitumor immunity |
2021-10-01 |
10.1136/jitc-2021-itoc8.25 |
Belnoue E, Das K, Rossi M, Hofer T, Danklmaier S, Nolden T, Schreiber L, Angerer K, Kimpel J, Hoegler S, Kenner L, von Laer D, Elbers K, Wollmann G, Derouazi M |
| 750529 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.05 Deciphering the function of the ubiquitin-proteasome-system in regulating the immune checkpoint protein B7-H3 (CD276) in non-small cell lung cancer |
2021-10-01 |
10.1136/jitc-2021-itoc8.9 |
Kurz M, Rieger L, Giansanti P, Kuster B, Bassermann F |
